课题基金 / 基金详情

Bigfoot Spectral Cell Sorter

Bigfoot Spectral Cell Sorter
Bigfoot 光谱细胞分选仪
批准号:
10419125
负责人:
Lawrence P. Kane
金额:
$75.49万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-09-15 至 2023-09-14
关键词:

项目摘要

项目成果

Lawrence P. Kane的其他基金

相似基金

相关文献

中文摘要
翻译
该申请是为购买生物含热费雪大脚光谱分选仪(7激光,60探测器)提供资金。
英文摘要
This request is for funds to purchase a biocontained ThermoFisher Bigfoot spectral sorter (7 laser, 60 detector). There is no full-spectrum cell sorter at the University of Pittsburgh or within 100 miles. Unique as an instrument, the Bigfoot sorter combines the strengths of high-parameter, high-content imaging (multi-laser, high-detector) with modern full-spectrum technologies (algorithmic spectral unmixing). Our ongoing NIH-funded research is hampered by the inability to directly transition complex, validated panels from Pitt's three spectral analyzers to an equivalent spectral cell sorter. In spectral approaches, the full spectrum of light emitted from each cell is collected by multiple detectors followed by unmixing to separate the signal into individual markers. Spectral cytometry expands parameter space by permitting the use of new fluors and also new combinations of existing fluors that could not previously be paired together in conventionally configured cytometers (i.e., one detector, one color systems). All of the sorters at Pitt are the conventional configuration type. The consequence is that most or all of our highly complex immunophenotypic spectral panels have to be scaled down, adapted to fewer detectors, and re-validated for compatibility with existing conventional sorters, all of which fails to capture the original complexity and novel information tantalizingly revealed by the spectral analyzers. Further, our current conventional sorters are heavily used. A very attractive feature of the Bigfoot is that it that has two operational modes, spectral and conventional. Thus, the Bigfoot meets the demands of users with high-complexity spectral sorting needs, and also benefits all users of our very busy core who have conventionally compensated needs. The requested Bigfoot spectral sorter will be housed within the centralized Unified Flow Cytometry Core in Pitt's School of Medicine. The core serves over 180 Pis and 500 individual users. For the proposed instrument, Major Users include 10 Pis (9 NIH funded) with another 7 Pis as Minor Users. Together, these Pis have over $30 Min NIH-funded direct costs from at least 5 different institutes. A major research focus is in the broad area of immunology and allied immune diseases, with sister disciplines such as transplantation, dermatology, vascular biology, infectious disease, and oncology also well represented. Our preliminary and demo work proved to us that this instrument will truly allow our investigators to break new ground in their research. The Bigfoot will be well cared for by the staff of the Unified Flow Cytometry Core, which has an extensive infrastructure and culture in place to support panel design, oversee instrument operations, and ensure that it is financially self-supporting. In addition to providing unique and much needed spectral sorting capabilities, the instrument will accommodate demands for configurable sorts including 6-way sorts into tubes and direct sorting into 1 Ox chips, and allow for better detection and efficient sorting of rarer events. The sorter has an integrated Class II biosafety cabinet. The requested Bigfoot will provide the first state-of-the-art spectral sorter instrumentation at Pitt to meet the high-complexity, high-content needs of our user base and advancing research programs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Regulation of PI3K by PIK3IP1/TrIP
Regulation of PI3K by PIK3IP1/TrIP
Regulation of T cell activation and exhaustion by Tim-3
Regulation of T cell activation and exhaustion by Tim-3
国内基金
海外基金
分化肌细胞脱细胞ECM-cells sheet 3D 支架构建及其促进容积性肌组织缺损再 生修复应用及机制研究
库否细胞(Kupffer cells)受体PirB/LILRB2在非酒精性脂肪性肝炎中的作用及机制研究
  • 批准号:
    82470907
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2024
  • 负责人:
    余学锋
  • 依托单位:
CAFs-TAMs-tumor cells调控在HRHPV感染致癌中的作用机制研究及AI可追溯预测模型建立
  • 批准号:
    82072862
  • 项目类别:
    面上项目
  • 资助金额:
    56.0万元
  • 批准年份:
    2020
  • 负责人:
    徐云升
  • 依托单位:
S100A8/A9--Myeloid cells特异性可溶性表氧化物水解酶(sEH)基因敲除改善胰岛素抵抗的新靶点
  • 批准号:
    82070825
  • 项目类别:
    面上项目
  • 资助金额:
    53.0万元
  • 批准年份:
    2020
  • 负责人:
    徐西振
  • 依托单位: